trial

Cognitive Behavioural Therapy- Social Functioning In Adolescence With Recent Onset Schizophrenia

NCTId NCT03217955
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 98 (actual)
Sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Primary completion 2017-03-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
98 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2014-05-06
Primary completion
2017-03-01
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
CBT-SAStandard treatment

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Lead Sponsor
ArkinCollaborator
Vroege Psychose ABC - UtrechtCollaborator
Centrum Eerste Psychose, Utrecht, NetherlandsCollaborator
GGZ inGeestCollaborator

Investigators

1
Lieuwe de Haan, Ph.D.Principal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
98
Phase
NA
Primary Completion Date
2017-03-01
Status
COMPLETED
relationships
The graph out of here
drug
CBT-SA
drug
Standard treatment
drug
lead_sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
company
collaborator
Arkin
company
Vroege Psychose ABC - Utrecht
company
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
investigator
Lieuwe de Haan, Ph.D.
person